Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study

被引：0
|
作者：
El Saadany, Tamer
Petrausch, Ulf
Mora, Alfonso Rojas
Winder, Thomas
Renner, Christoph
Benda, Magdalena
Reimann, Patrick
Froesch, Patrizia
Jakob, Andreas
Daza, Adriana Clavijo
Mueller, Gisela
Von Moos, Roger Anton Fredy
Mark, Michael Thomas
机构：
[1] Kantonsspital Graubuenden, Div Hematol Oncol, Chur, Switzerland
[2] Hirslanden Zurich, Div Hematol Oncol, Zurich, Switzerland
[3] Swiss Grp Clin Canc Res SAKK, Competence Ctr, Bern, Switzerland
[4] Landeskrankenhaus Feldkirch, Internal Med 2, Feldkirch, Austria
[5] Swiss Tumor Inst, Zurich, Switzerland
[6] Hosp Feldkirch, Div Hematol Oncol, Feldkirch, Austria
[7] Hosp Feldkirch, Div Hematol Oncol, Dept Internal Med 2, Feldkirch, Austria
[8] Ente Osped Cantonale EOC, Oncol Inst Southern Switzerland IOSI, Bellinzona, Switzerland
[9] Tumor Zentrum Aarau, Aarau, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6619
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
    Paderi, Agnese
    Gambale, Elisabetta
    Botteri, Cristina
    Giorgione, Roberta
    Lavacchi, Daniele
    Brugia, Marco
    Mazzoni, Francesca
    Giommoni, Elisa
    Bormioli, Susanna
    Amedei, Amedeo
    Pillozzi, Serena
    Matucci Cerinic, Marco
    Antonuzzo, Lorenzo
    MOLECULES, 2021, 26 (19):
  • [32] OUTCOMES IN PATIENTS WITH PRE-EXISTING AUTOIMMUNE DISEASES WHO RECEIVED IMMUNE CHECKPOINT INHIBITORS: A REAL-WORLD STUDY
    Pavlick, Anna
    Palaia, Jennell
    Pisupati, Radhika
    Fu, Benjamin
    Wittstock, Keith
    Zhang, Ying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A461 - A461
  • [33] Clinical predictive factors in real world setting in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Callejo, A.
    Marmolejo, D.
    Iranzo, P.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S766 - S766
  • [34] Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
    Benkhadra, Maria
    Elazzazy, Shereen
    Hamad, Anas Ahmad
    Elkhatim, Mohamed S.
    Gulied, Amaal
    Sahal, Arwa Osama
    Alasmar, Aya
    Jibril, Farah I.
    Afifi, Hebatalla Mahmoud
    Nasser, Sahar
    Alnajjar, Afnan
    Dawoud, Rawan
    Omar, Nabil E.
    BLOOD, 2023, 142
  • [35] Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
    Lumlertgul, Nuttha
    Vassallo, Pietro
    Tydeman, Florence
    Lewis, Natasha
    Hobill, Abigail
    Weerapolchai, Kittisak
    Nordin, Nurul Zaynah
    Seylanova, Nina
    Martin, Luke
    Cennamo, Armando
    Wang, Yanzhong
    Rigg, Anne
    Shaunak, Nisha
    Ostermann, Marlies
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [36] Real-world usage and outcomes for patients treated with immune checkpoint inhibitors across multiple treatment indications in the Veterans Affairs system.
    La, Jennifer
    Cheng, David
    Nhan Do
    Brophy, Mary T.
    Fillmore, Nathanael
    Tuck, David P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study
    Calleja-Chucla, Teresa
    Gonzalez, Patricia Cordeiro
    Pradeda, Alejandro Martinez
    Pertega-Diaz, Sonia
    Margusino-Framinan, Luis
    Novoa, Silvia Antolin
    BIOMEDICINES, 2025, 13 (02)
  • [38] Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI).
    Rogiers, Aljosja
    Tondini, Carlo
    Grimes, Joe M.
    Trager, Megan H.
    Nahm, Sharon
    Zubiri, Leyre
    Papneja, Neha
    Elkrief, Arielle
    Borgers, Jessica
    Rose, April
    Mangana, Johanna
    Erdmann, Michael
    da Silva, Ines Pires
    Posch, Christian
    Hauschild, Axel
    Zimmer, Lisa
    Queirolo, Paola
    Robert, Caroline
    Suijkerbuijk, Karijn
    Ascierto, Paolo A.
    Lorigan, Paul
    Carvajal, Richard
    Rahma, Osama E.
    Mandala, Mario
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2020, 26 (18)
  • [39] Development of a novel immune-related toxicity grading system for predicting outcomes in patients with solid tumours treated with immune checkpoint inhibitors (ICI)
    Kapiris, Matthaios
    Santaolalla, Aida
    Bratsos, Sosipatros
    Ghunam, Sundeep
    McDonald, Louisa
    Muhith, Moe
    Wu, Yin
    Georgiou, Alexandros
    Josephs, Debra Hannah
    Sarker, Debashis
    Cope, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
    Ariyasu, Ryo
    Kakuto, Sho
    Miyadera, Keiki
    Akita, Takahiro
    Kiritani, Ayu
    Tsugitomi, Ryosuke
    Amino, Yoshiaki
    Uchibori, Ken
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (06):
12345